India
Pfizer Ltd.
2molecules
2product records
0with list price
Infliximab Immunology & rheumatology
Originator: Remicade · Janssen Biotech / Johnson & Johnson (originally Centocor); initial U.S. approval 1998
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Inflectra (infliximab-dyyb) and Ixifi (infliximab-qbtx) | 100 mg vial | — | — | — | — |
Lorlatinib Cancer (oncology)
Originator: Lorbrena · Pfizer Inc.
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Lorbriqua | 25 mg and 100 mg tablets | — | — | — | — |
Medical and legal notice
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.